Stay updated on MK-3475 Combo vs Docetaxel Alone in NSCLC Clinical Trial
Sign up to get notified when there's something new on the MK-3475 Combo vs Docetaxel Alone in NSCLC Clinical Trial page.

Latest updates to the MK-3475 Combo vs Docetaxel Alone in NSCLC Clinical Trial page
- Check3 days agoChange DetectedAdded a glossary toggle (Show glossary) and a new QC update label 'Last Update Submitted that Met QC Criteria' (replacing the previous 'Last Update Submitted that met QC Criteria'). Updated the No FEAR Act notice to 'No FEAR Act data' and the page revision from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision indicator has been updated to v3.3.4 (replacing v3.3.3); no study content or user interactions are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedLocations section added and Mexico City is listed as a study site. The previous Mexico City Locations entry was removed, and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.2%

- Check68 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and updated the revision to v3.3.2, replacing the previous PubMed note and revision v3.2.0.SummaryDifference0.1%

- Check75 days agoChange DetectedThe notice about a lapse in government funding and operating status was removed from the page.SummaryDifference0.4%

- Check96 days agoChange DetectedNo additions or deletions were detected; the page content and layout remain as before.SummaryDifference0.4%

Stay in the know with updates to MK-3475 Combo vs Docetaxel Alone in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-3475 Combo vs Docetaxel Alone in NSCLC Clinical Trial page.